Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-04-29Clinical Trial Update: Improving Medication Adherence Among People With Schizophrenia Through the Use of 2-way Pagers [NA]
Completed clinical trial evaluated the use of two-way pagers to improve medication adherence in people with schizophrenia; results were post…
-
FDA approval · 2014-04-28FDA Approved: RISPERDAL — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for Risperdal (risperidone) from Janssen Pharmaceuticals, Inc. The approval updates the drug's label…
-
FDA approval · 2014-04-28FDA Approved: RISPERDAL CONSTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for RISPERDAL CONSTA (risperidone) from Janssen Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2014-04-28Clinical Trial Update: Effects of Pravastatin on Cholesterol, Inflammation and Cognition in Schizophrenia [Phase 4]
Phase 4 clinical trial explored the effects of pravastatin on cholesterol, inflammation, and cognition in individuals with schizophrenia and…
-
CLINICAL_TRIALS trial_result · 2014-04-28Clinical Trial Update: INVISION - An Observational Study to Explore Effectiveness, Tolerability and Safety of Paliperidone ER in Patients With Schizophrenia
An observational study evaluating the effectiveness, tolerability, and safety of paliperidone extended-release in adults with schizophrenia …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-04-25Clinical Trial Update: Safety and Cognitive Function Study of EVP-6124 in Patients With Schizophrenia [Phase 2]
This update summarizes the completion of a Phase 2 safety and cognitive function study of EVP-6124 in patients with schizophrenia. The trial…
-
CLINICAL_TRIALS research · 2014-04-25Clinical Trial Update: Measuring the Effect of Remote Monitoring of Treatment Adherence on the Risk of Re-admission of Ambulatory Schizophrenic Patients [NA]
This clinical trial update describes a study evaluating whether remote monitoring of treatment adherence affects readmission risk among ambu…
-
FDA approval · 2014-04-22FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for quetiapine fumarate submitted by BluePoint Laboratories. This action grants updated regulatory a…
-
CLINICAL_TRIALS trial_result · 2014-04-17Clinical Trial Update: A 4-week, Randomized, Rater-blinded, Parallel Study to Evaluate Quetiapine in Improving Sleep Quality of Schizophrenia [NA]
A 4-week randomized, rater-blinded study assessed quetiapine for improving sleep quality in individuals with schizophrenia; results were pos…
-
CLINICAL_TRIALS trial_result · 2014-04-16Clinical Trial Update: A Pilot Trial of Acute N-Acetylcysteine Effects on Working Memory and Other Cognitive Functions in Schizophrenia [NA]
A Yale-sponsored pilot trial evaluated the acute effects of N-acetylcysteine on working memory and other cognitive functions in schizophreni…
-
CLINICAL_TRIALS trial_result · 2014-04-10Clinical Trial Update: Pragmatic RCT Comparing Aripiprazole, Olanzapine and Haloperidol in the Treatment of Schizophrenia [Phase 4]
A Phase 4 pragmatic randomized trial comparing aripiprazole, olanzapine, and haloperidol for schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2014-04-09Clinical Trial Update: Comparison of the Effects of Aripiprazole and Risperidone on the Pattern of Brain Activation in Schizophrenic Patients [Phase 4]
Phase 4 clinical trial comparing aripiprazole and risperidone on brain activation patterns in patients with schizophrenia, with results post…
-
CLINICAL_TRIALS trial_result · 2014-04-09Clinical Trial Update: Schizophrenia Treatment Adherence Investigation (STAI)
This is a completed clinical trial update for the STAI schizophrenia treatment adherence study sponsored by Janssen-Cilag Pty Ltd, evaluatin…
-
CLINICAL_TRIALS trial_result · 2014-04-08Clinical Trial Update: A Drug Interaction Study of Valproic Acid and Paliperidone Extended-Release (ER) in Patients With Schizophrenia, Bipolar I Disorder, or Schizoaffective Disorder [Phase 1]
Phase 1 study evaluating the potential drug interaction between valproic acid and paliperidone extended-release in adults with schizophrenia…
-
CLINICAL_TRIALS trial_result · 2014-04-08Clinical Trial Update: Ketamine Challenge Study With JNJ-40411813 [Phase 1]
Phase 1 ketamine challenge study of JNJ-40411813 by Johnson & Johnson Pharmaceutical Research & Development has completed. The trial explore…
-
CLINICAL_TRIALS trial_result · 2014-04-04Clinical Trial Update: Observational Study in Patients With Schizophrenia Treated With Long-Acting Risperidone Injection (RISPERDAL CONSTA)
An observational study assessing outcomes in schizophrenia patients treated with the long-acting injectable risperidone (RISPERDAL CONSTA) h…
-
CLINICAL_TRIALS research · 2014-04-03Clinical Trial Update: A Study to Evaluate Treatment Adherence in Schizophrenia With Long Acting Risperidone Microspheres (e-STAR)
A completed clinical trial (e-STAR) evaluated adherence to schizophrenia treatment with long-acting risperidone microspheres.
-
CLINICAL_TRIALS trial_result · 2014-04-02Clinical Trial Update: Molecular Genetics of Schizophrenia
A completed clinical trial investigating the molecular genetics of schizophrenia conducted by Endeavor Health.
-
FDA approval · 2014-03-28FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for GEODON (ziprasidone mesylate) submitted by Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2014-03-27Clinical Trial Update: Efficacy Study of Paliperidone to Evaluate Subjective Change in Well-being and Drug Attitude in Schizophrenic Participants [Phase 4]
This document reports the results of a Phase 4 study evaluating Paliperidone's effect on subjective well-being and drug attitude in individu…
-
CLINICAL_TRIALS trial_result · 2014-03-26Clinical Trial Update: Safety, Efficacy and Tolerability Study of Paliperidone Extended-Release (ER) in Participants With Schizophrenia [Phase 3]
Phase 3 clinical trial evaluating safety, efficacy, and tolerability of Paliperidone Extended-Release in adults with schizophrenia; the stud…
-
CLINICAL_TRIALS trial_result · 2014-03-26Clinical Trial Update: An Efficacy and Safety Study of 3 Fixed Doses of JNJ-37822681 in Participants With Schizophrenia [Phase 2]
This clinical trial update reports on a Phase 2 efficacy and safety study of three fixed doses of JNJ-37822681 in schizophrenia, sponsored b…
-
CLINICAL_TRIALS trial_result · 2014-03-26Clinical Trial Update: Association of Amisulpride Response in Schizophrenia With Brain Image [Phase 4]
A Phase 4 clinical trial update examining the association between brain imaging findings and response to amisulpride in schizophrenia and sc…
-
CLINICAL_TRIALS trial_result · 2014-03-26Clinical Trial Update: Treatment of Early Onset Schizophrenia Spectrum Disorders (TEOSS) [Phase 4]
Phase 4 TEOSS trial for early onset schizophrenia spectrum disorders has completed; results were posted in March 2014.
-
FDA approval · 2014-03-25FDA Approved: VERSACLOZ — Supplemental Application (TruPharma LLC)
FDA approved a supplemental application for VERSACLOZ (clozapine) from TruPharma LLC, updating the labeling per the supplemental filing.